• 제목/요약/키워드: Active pharmaceutical ingredient

검색결과 60건 처리시간 0.022초

유익하게 인체에 작용하는 균(유인균)을 이용한 인삼발효식초 제조과정에 대한 특성연구 (A Study on the Vinegar Fermentation Processes of Fresh Korean Ginseng Extract Using Mix Microbial Yinkin)

  • 황세란;데스티아니 수페노;권순홍;정성원;권순구;박종민;김종순;최원식
    • 한국산업융합학회 논문집
    • /
    • 제20권4호
    • /
    • pp.345-350
    • /
    • 2017
  • Saponin is the most pharmaceutical active ingredients of the ginseng plant, it was called "Ginsenoside" which means the Glycoside of ginseng that composed glycosides and aglycones. The human body will absorb the saponin easily if these substrate was decomposed by active microorganism. Fermentation is the most convenient technique to decompose this active ingredients. The purpose of this research was to study the sugar content, pH and acidity development during the ginseng fermentation process. Fresh Korean ginseng and red ginseng extract was used as the main ingredient. The concentrated of pure ginseng extract was added to increase the saponin extract. Furthermore, the mix microbial powder was added as starter to increase the fermentation efficiency. The ginseng was fermented in fermentation chamber at temperature $37^{\circ}C$ during 70 days. In the end of experiment the sugar content was decreased from 24% to 7.65%, The pH was decreased from 6.5 to 3.4, and the acidity level was incresed from 0% to 1.2%.

항생제 분해용 광촉매막: 리뷰 (Photocatalytic Membrane for Degradation of Antibiotics: A Review)

  • 라비아 카갛니;라즈쿠마 파텔
    • 멤브레인
    • /
    • 제32권5호
    • /
    • pp.304-313
    • /
    • 2022
  • 활성 의약품 성분(APIs)의 존재가 수생 생태계와 인간의 건강에 위험하다는 증거가 있다. 물에 항생물질인 테트라사이클린과 같은 API가 존재하면 미생물에 항균제 내성(AMR)이 발생해 개인과 사회에 막대한 비용이 발생한다. TiO2 또는 비스무트 기반 촉매와 같은 촉매가 내장된 막은 유기 유출물을 분해하고 폐수로부터 분리한다. 촉매의 광촉매 활성은 귀금속 도핑 및 탄소성 물질의 첨가 및 다른 반도체와의 헤테로 접합 형성으로 향상될 수 있다. 광촉매의 회수는 고분자 막에서 광촉매의 고정화를 통해 가능하다. 이 검토에서는 물 속 항생제의 분해가 논의된다.

Quantitative analysis and validation of naproxen tablets by using transmission raman spectroscopy

  • Jaejin Kim;Janghee Han;Young-Chul Lee;Young-Ah Woo
    • 분석과학
    • /
    • 제37권2호
    • /
    • pp.114-122
    • /
    • 2024
  • A transmission Raman spectroscopy-based quantitative model, which can analyze the content of a drug product containing naproxen sodium as its active pharmaceutical ingredient (API), was developed. Compared with the existing analytical method, i.e., high-performance liquid chromatography (HPLC), Raman spectroscopy exhibits high test efficiency owing to its shorter sample pre-treatment and measurement time. Raman spectroscopy is environmentally friendly since samples can be tested rapidly via a nondestructive method without sample preparation using solvent. Through this analysis method, rapid on-site analysis was possible and it could prevent the production of defective tablets with potency problems. The developed method was applied to the assays of the naproxen sodium of coated tablets that were manufactured in commercial scale and the content of naproxen sodium was accurately predicted by Raman spectroscopy and compared with the reference analytical method such as HPLC. The method validation of the new approach was also performed. Further, the specificity, linearity, accuracy, precision, and robustness tests were conducted, and all the results were within the criteria. The standard error of cross-validation and standard error of prediction values were determined as 0.949 % and 0.724 %, respectively.

외용겔 및 다중유제크림의 코지산 방출특성과 피부자극성 (Drug Release Characteristics and Skin Irritancies of Topical Gels and Multiple Emulsion Creams Containing Kojic Acid)

  • 유성운;박은우;최영욱
    • Journal of Pharmaceutical Investigation
    • /
    • 제28권2호
    • /
    • pp.87-92
    • /
    • 1998
  • Kojic acid (KA) is an antimelanogenic agent which has been widely used in cosmetics to whiten the skin color. However, it has the drawbacks of the skin irritancy and the instability against the pH, temperature, and light. In order to overcome these problems, various topical gels and multiple emulsion creams which can control the release of active ingredient, KA, were formulated employing cream bases of mineral oil with caprylic capric triglyceride and hydrophilic polymers such as chitosan, carbopol. and pluronics. Using Franz diffusion cells mounted with a synthetic cellulose membrane (MWCO 12,000), drug release characteristics of the formulations were evaluated by the HPLC assay of KA concentration in the receptor compartment of pH 7.4 phosphate buffered saline solution. Drug release from chitosan-based gels (ChitoGel) obeyed to the first order kinetics with a rapid release especially in the initial period. However, pluronic-based gels (PluGel) and carbopol-based gels (CarboGel) revealed controlled release of drug to some extent, followed by the square root-time kinetics. Moreover, the release of KA was further controlled with the W/O/W multiple emulsion creams (MultiCream), showing the apparent zero order release kinetics by virtue of dynamic ratecontrolling membrane of the oil layer. The flux $(J,\;{\mu}g/cm^2/hr)$ of ChitoGel. CarboGel. PluGel. and MultiCream in the initial period of 6hr were 73.30, 28.67. 24.04 and 7.72, respectively. On the other hand, the skin irritancy score of ChitoGel and MultiCream were observed as 2.5 and 2.3 respectively, in the rabbit skin irritation test. Although there were insignificant differences at p<0.05 between those formulations, it was possible to conclude that the W/O/W multiple emulsion creams containing KA might be a good candidate for an antimelanogenic drug delivery system due to the controlled release of acidic drug molecules.

  • PDF

근린약국에서 산제로 조제된 아테놀올정의 안정성 (Stability of Atenolol Tablet After Dispensing to Powder form at Community Pharmacies)

  • 용철순;최한곤;이종달;유봉규
    • Journal of Pharmaceutical Investigation
    • /
    • 제34권4호
    • /
    • pp.299-303
    • /
    • 2004
  • Prescription filling in powder form is performed in community pharmacy practice to adjust dose for children and patients who cannot swallow whole tablet. However, there are few reports regarding the stability of the active ingredient and possible microbial growth after the medication is dispensed to powder form. This study examined the stability of atenolol, an antihypertensive agent, and microbial growth in the unit dose pouches dispensed at twenty-one community pharmacies located in Taegu area. Randomly chosen first unit dose pouch contained 77.4% of the prescribed dose of the drug and there were only four community pharmacies that dispensed the drug within 10% deviation from the dose prescribed by physician. Surprisingly, there were three community pharmacies that dispensed the drug with greater than 40% deviation, which may pose a major concern regarding the efficacy and safety of the drug prescribed for the treatment of hypertension. Atenolol content during a month did not indicate significant change, showing 5.4%, 4.3%, and 3.3% of decrease in 50%, 80%, and 90% relative humidity conditions, respectively. Microbiological examination during a month showed less than 0.5 microorganism in high power field (hpf) in all the relative humidity conditions tested. Based on this study, pharmacy practice in community pharmacy needs to be rigorously regulated to ensure that the dose of the prescribed drug is properly incorporated into the unit dose pouch dispensed as powder form.

Luteolin-7-𝑂-glucoside가 멜라닌 합성에 미치는 영향 (Effects of Luteolin-7-𝑂-glucoside on melanin synthesis)

  • 최병민;홍혜현;박태진;김승영
    • Journal of Applied Biological Chemistry
    • /
    • 제65권3호
    • /
    • pp.231-237
    • /
    • 2022
  • Biorenovation은 미생물의 효소 작용을 통해 기존의 화합물을 새로운 화합물로 전환시키는 방법이다. 본 연구에서는 biorenovation을 Luteolin에 적용하여 Luteolin-7-O-glucoside (L7G)를 합성하였으며 L7G의 미백 기능성을 평가하고자 α-MSH로 유도된 B16F10 mouse melanoma 세포에서 실험을 진행하였다. L7G는 Luteolin의 높은 세포독성을 개선하였으며 세포 독성이 나타나지 않는 농도에서 melanin 합성 및 tyrosinase 생성을 유의하게 억제하였다. 또한 western blot을 통해 멜라닌의 합성 인자들의 발현을 조사한 결과 tyrosinase와 MITF의 발현이 효과적으로 억제되는 것을 확인하였다. 결론적으로 우리는 L7G가 멜라닌의 합성을 억제함으로써 피부 미백에 긍정적인 영향을 나타낼 수 있음을 확인하였으며 이러한 결과를 근거로 L7G가 미백 기능성 원료로써 활용 가능함을 제안한다.

의약품 중 잠재적 불순물 관리를 위한 분석법 연구 동향 (Analytical methods to manage potential impurities in drug substances)

  • 박경민;김원미;안수현;이하림;황수현;이원웅;홍종기
    • 분석과학
    • /
    • 제35권3호
    • /
    • pp.93-115
    • /
    • 2022
  • 의약품의 제조, 유통, 보관 과정에서 발생할 수 있는 잠재적 불순물은 의약품의 품질과 안전에 영향을 미치며 반응성이 높은 불순물의 경우 인체에 대한 발암성(변이원성)을 나타내기도 한다. 이를 위해 국제의약품규제조화위원회(International Conference on Harmonisation, ICH)에서는 "잠재적 발암 위해를 제한하기 위한 의약품 중 DNA 반응성(변이원성) 불순물의 평가 및 관리"에 대한 내용을 담은 M7(R1) 가이드라인을 제공하여 채택을 권고하였다. 하지만 가이드라인에서도 잠재적 불순물에 대한 분류, 섭취 허용량, 관리방안 등과 대표적인 불순물 14 종에 대한 가이드라인 적용을 소개하는데 그치고 있어 제약회사와 규제 당국에서 실제 관리를 위한 의약품 중 잠재적 불순물의 분석에 어려움을 겪고 있다. 이에 따라 본 총설에서는 비의도적 변이원성 불순물의 정의와 ICH M7(R1) 가이드라인에 소개된 내용을 간략하게 살펴보는 한편 현재까지 보고된 주요 잠재적 불순물의 분석 동향을 살펴보고자 한다. 이를 통해 식약처를 비롯한 감독 기관과 제약회사 등에서 의약품 중 잠재적 불순물 관리에 조금이나마 도움이 되고자 한다.

호흡기계 작용 약물의 치료군 중복처방 평가기준 개발 (Therapeutic Duplication Criteria Development of Respiratory System Drugs)

  • 최경업;손현순;김남효;신현택;이영숙
    • 약학회지
    • /
    • 제56권2호
    • /
    • pp.126-135
    • /
    • 2012
  • Purpose: To develop therapeutic duplication criteria for the drugs used for respiratory diseases. Method: Therapeutic duplication was defined as "more than 2 drug ingredient-usage in which each has the same therapeutic effect and combination therapy does not confer additional therapeutic benefit". Respiratory system drugs approved in Korea were examined for the study. The WHO's Anatomical Therapeutic Chemical Classification System was used for grouping of the corresponding drug ingredients. The principles and recommendations on combination usage or multiple drug regimens were reviewed by using the clinical practice guidelines, textbooks, product labelings, and clinical articles. Clinical expert group consultation was performed and expert opinions were incorporated into the final criteria. Results: Nine hundred sixty two drug products with Korean Food and Drug Administration classification codes of 141, 149, 222, and 229 were evaluated, of which 87 active ingredients were composed. The drug ingredients were classified into 12 groups (antihistamines, oral nasal decongestants, leukotriene receptor antagonists, inhaled anticholinergics, inhaled corticosteroids, oral ${\beta}2$-agonists, long-acting ${\beta}2$-agonists, short-acting ${\beta}2$-agonists, xanthines, antiallergics, mucolytics and cough suppressants). The use of more than 2 drug ingredients including the same group was therapeutic duplication, and thus combination should be recommended not to be used. Conclusion: Twelve drug groups were identified as therapeutic duplication criteria. Combination therapy within each group should not be used otherwise therapeutic benefits outweigh potential risks.

Synthesis and Properties of 5-Aminosalicyl-taurine as a Colon-specific Prodrug of 5-Aminosalicylic Acid

  • Jung, Yun-Jin;Kim, Hak-Hyun;Kong, Hye-Sik;Kim, Young-Mi
    • Archives of Pharmacal Research
    • /
    • 제26권4호
    • /
    • pp.264-269
    • /
    • 2003
  • 5-Aminosalicylic acid (5-ASA) is an active ingredient of therapeutic agents used for Crohn s disease and ulcerative colitis. Because it is absorbed rapidly and extensively in the upper intestine, delivery of the agent specifically to the colon is necessary. We selected taurine as a colon-specific promoiety and designed 5-aminosalicyltaurine (5-ASA-Tau) as a new colon-specific prodrug of 5-aminosalicylic acid (5-ASA). It was expected that introduction of taurine would restrict the absorption of the prodrug and show additive effect to the anti-inflammatory action of 5-ASA after hydrolysis. 5-ASA-Tau was prepared in good yield by a simple synthetic route. The apparent partition coefficient of 5-ASA-Tau in 1-octanol/pH 6.8 phosphate buffer or $CHCl_3$/pH 6.8 phosphate buffer was 0.10 or 0.18, respectively, at $37^{\circ}C$. To determine the chemical and biochemical stability in the upper intestinal environment, 5-ASA-Tau was incubated in pH 1.2 and 6.8 buffer solutions, and with the homogenates of tissue and contents of stomach or small intestine of rats at $37^{\circ}C$. 5-ASA was not detected from any of the incubation medium with no change in the concentration of 5-ASA-Tau. On incubation of 5-ASA-Tau with the cecal and colonic contents of rats, the fraction of the dose released as 5-ASA was 45% and 20%, respectively, in 8 h. Considering low partition coefficient and stability in the upper intestine, 5-ASA-Tau might be nonabsorbable and stable in the upper intestine. After oral administration, it would be delivered to the colon in intact form and release 5-ASA and taurine. These results suggested 5-ASA-Tau as a promising colon-specific prodrug of 5-ASA.

화재폭발지수 개선에 대한 사례 연구 (Case Study on Advanced Fire and Explosion Index)

  • 나건문;서재민;이미정;백종배
    • 한국안전학회지
    • /
    • 제35권6호
    • /
    • pp.78-84
    • /
    • 2020
  • The F&EI technique is one of the risk assessments with many advantages. It can save time and effort compared to quantitative risk assessment (QRA). By using the evaluation result of this technique, it is possible to check the effectiveness of the investment cost. In addition, a relative risk ranking can be created and used to establish the facility management cycle and to prioritize investment. However, evaluating the target process can be evaluated more than the actual risk since the LCCF, a loss prevention measure, is too limited. In addition, calculating premiums via this method can result in excessive premiums, making it difficult to evaluate the risk precisely. Therefore, new safety guard was added to the LCCF of the F&EI risk assessment with reference to HAZOP and LOPA techniques. Newly added LCCFs are Deflagration arrester, Check valve, SIS, and Vacuum beaker, etc. As a case study, F&EI risk assessment was performed on Acetone storage tank of a API (Active pharmaceutical ingredient) plant to compare actual MPPD. The estimated loss amount was 592,558$ for the existing technique and 563,571$ for the improved technique, which was reduced by about 5% compared to the previous one.This proved that a more precise evaluation is possible and that the efforts for safety at the workplace are reflected in the evaluation results.